 | • レポートコード：D0804-09034 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、100ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ニボルマブ注射の世界市場を広く調査・分析し、今後の市場展望をまとめております。ニボルマブ注射の種類別市場規模（100IU、50IU、その他）、用途別市場規模（切除不能黒色腫、転移性黒色腫、転移性扁平上皮NSCLC、古典的ホジキンリンパ腫、腎細胞癌、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：AbbVie、Sinopharm、Allergan、Ono Pharmaceutical、Bristol-Myers Squibb ・地域別グローバル市場分析 2015年-2020年 ・ニボルマブ注射の北米市場（アメリカ、カナダ、メキシコ） ・ニボルマブ注射のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ニボルマブ注射のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ニボルマブ注射の南米市場（ブラジル、アルゼンチン） ・ニボルマブ注射の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：100IU、50IU、その他 ・用途別分析：切除不能黒色腫、転移性黒色腫、転移性扁平上皮NSCLC、古典的ホジキンリンパ腫、腎細胞癌、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Nivolumab Injection market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Nivolumab Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Nivolumab Injection market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Nivolumab Injection market has been segmented into
100IU
50IU
Other
By Application, Nivolumab Injection has been segmented into:
Unresectable Melanoma
Metastatic Melanoma
Metastatic Squamous NSCLC
Classical Hodgkin Lymphoma
Renal Cell Carcinoma
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Nivolumab Injection market presented in the report. This section sheds light on the sales growth of different regional and country-level Nivolumab Injection markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Nivolumab Injection market.
The report offers in-depth assessment of the growth and other aspects of the Nivolumab Injection market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Nivolumab Injection Market Share Analysis
Nivolumab Injection competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Nivolumab Injection sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Nivolumab Injection sales, revenue and market share for each player covered in this report.
The major players covered in Nivolumab Injection are:
AbbVie
Sinopharm
Allergan
Ono Pharmaceutical
Bristol-Myers Squibb
Among other players domestic and global, Nivolumab Injection market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nivolumab Injection product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nivolumab Injection, with price, sales, revenue and global market share of Nivolumab Injection in 2018 and 2019.
Chapter 3, the Nivolumab Injection competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nivolumab Injection breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Nivolumab Injection market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Nivolumab Injection sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Nivolumab Injection Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nivolumab Injection Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 100IU
1.2.3 50IU
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Nivolumab Injection Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Unresectable Melanoma
1.3.3 Metastatic Melanoma
1.3.4 Metastatic Squamous NSCLC
1.3.5 Classical Hodgkin Lymphoma
1.3.6 Renal Cell Carcinoma
1.3.7 Other
1.4 Overview of Global Nivolumab Injection Market
1.4.1 Global Nivolumab Injection Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AbbVie SWOT Analysis
2.1.4 AbbVie Product and Services
2.1.5 AbbVie Nivolumab Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sinopharm
2.2.1 Sinopharm Details
2.2.2 Sinopharm Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sinopharm SWOT Analysis
2.2.4 Sinopharm Product and Services
2.2.5 Sinopharm Nivolumab Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Allergan
2.3.1 Allergan Details
2.3.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Allergan SWOT Analysis
2.3.4 Allergan Product and Services
2.3.5 Allergan Nivolumab Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Ono Pharmaceutical
2.4.1 Ono Pharmaceutical Details
2.4.2 Ono Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Ono Pharmaceutical SWOT Analysis
2.4.4 Ono Pharmaceutical Product and Services
2.4.5 Ono Pharmaceutical Nivolumab Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bristol-Myers Squibb
2.5.1 Bristol-Myers Squibb Details
2.5.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Bristol-Myers Squibb SWOT Analysis
2.5.4 Bristol-Myers Squibb Product and Services
2.5.5 Bristol-Myers Squibb Nivolumab Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Nivolumab Injection Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Nivolumab Injection Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Nivolumab Injection Manufacturer Market Share in 2019
3.3.2 Top 6 Nivolumab Injection Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Nivolumab Injection Sales, Revenue and Market Share by Regions
4.1.1 Global Nivolumab Injection Sales and Market Share by Regions (2015-2020)
4.1.2 Global Nivolumab Injection Revenue and Market Share by Regions (2015-2020)
4.2 North America Nivolumab Injection Sales and Growth Rate (2015-2020)
4.3 Europe Nivolumab Injection Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Nivolumab Injection Sales and Growth Rate (2015-2020)
4.5 South America Nivolumab Injection Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Nivolumab Injection Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Nivolumab Injection Sales, Revenue and Market Share by Country
5.1.1 North America Nivolumab Injection Sales and Market Share by Country (2015-2020)
5.1.2 North America Nivolumab Injection Revenue and Market Share by Country (2015-2020)
5.2 United States Nivolumab Injection Sales and Growth Rate (2015-2020)
5.3 Canada Nivolumab Injection Sales and Growth Rate (2015-2020)
5.4 Mexico Nivolumab Injection Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Nivolumab Injection Sales, Revenue and Market Share by Country
6.1.1 Europe Nivolumab Injection Sales and Market Share by Country (2015-2020)
6.1.2 Europe Nivolumab Injection Revenue and Market Share by Country (2015-2020)
6.2 Germany Nivolumab Injection Sales and Growth Rate (2015-2020)
6.3 UK Nivolumab Injection Sales and Growth Rate (2015-2020)
6.4 France Nivolumab Injection Sales and Growth Rate (2015-2020)
6.5 Russia Nivolumab Injection Sales and Growth Rate (2015-2020)
6.6 Italy Nivolumab Injection Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Nivolumab Injection Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Nivolumab Injection Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Nivolumab Injection Revenue and Market Share by Regions (2015-2020)
7.2 China Nivolumab Injection Sales and Growth Rate (2015-2020)
7.3 Japan Nivolumab Injection Sales and Growth Rate (2015-2020)
7.4 Korea Nivolumab Injection Sales and Growth Rate (2015-2020)
7.5 India Nivolumab Injection Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Nivolumab Injection Sales and Growth Rate (2015-2020)
7.7 Australia Nivolumab Injection Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Nivolumab Injection Sales, Revenue and Market Share by Country
8.1.1 South America Nivolumab Injection Sales and Market Share by Country (2015-2020)
8.1.2 South America Nivolumab Injection Revenue and Market Share by Country (2015-2020)
8.2 Brazil Nivolumab Injection Sales and Growth Rate (2015-2020)
8.3 Argentina Nivolumab Injection Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Nivolumab Injection Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Nivolumab Injection Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Nivolumab Injection Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Nivolumab Injection Sales and Growth Rate (2015-2020)
9.3 Turkey Nivolumab Injection Sales and Growth Rate (2015-2020)
9.4 Egypt Nivolumab Injection Sales and Growth Rate (2015-2020)
9.5 South Africa Nivolumab Injection Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Nivolumab Injection Sales and Market Share by Type (2015-2020)
10.2 Global Nivolumab Injection Revenue and Market Share by Type (2015-2020)
10.3 Global Nivolumab Injection Price by Type (2015-2020)
11 Global Nivolumab Injection Market Segment by Application
11.1 Global Nivolumab Injection Sales Market Share by Application (2015-2020)
11.2 Global Nivolumab Injection Revenue Market Share by Application (2015-2020)
11.3 Global Nivolumab Injection Price by Application (2015-2020)
12 Market Forecast
12.1 Global Nivolumab Injection Sales, Revenue and Growth Rate (2021-2025)
12.2 Nivolumab Injection Market Forecast by Regions (2021-2025)
12.2.1 North America Nivolumab Injection Market Forecast (2021-2025)
12.2.2 Europe Nivolumab Injection Market Forecast (2021-2025)
12.2.3 Asia-Pacific Nivolumab Injection Market Forecast (2021-2025)
12.2.4 South America Nivolumab Injection Market Forecast (2021-2025)
12.2.5 Middle East & Africa Nivolumab Injection Market Forecast (2021-2025)
12.3 Nivolumab Injection Market Forecast by Type (2021-2025)
12.3.1 Global Nivolumab Injection Sales Forecast by Type (2021-2025)
12.3.2 Global Nivolumab Injection Market Share Forecast by Type (2021-2025)
12.4 Nivolumab Injection Market Forecast by Application (2021-2025)
12.4.1 Global Nivolumab Injection Sales Forecast by Application (2021-2025)
12.4.2 Global Nivolumab Injection Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Nivolumab Injection Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Nivolumab Injection by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Nivolumab Injection Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. AbbVie Basic Information, Manufacturing Base and Competitors
Table 8. AbbVie Nivolumab Injection Major Business
Table 9. AbbVie Nivolumab Injection Total Revenue (USD Million) (2018-2019)
Table 10. AbbVie SWOT Analysis
Table 11. AbbVie Nivolumab Injection Product and Services
Table 12. AbbVie Nivolumab Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Sinopharm Basic Information, Manufacturing Base and Competitors
Table 14. Sinopharm Nivolumab Injection Major Business
Table 15. Sinopharm Nivolumab Injection Total Revenue (USD Million) (2018-2019)
Table 16. Sinopharm SWOT Analysis
Table 17. Sinopharm Nivolumab Injection Product and Services
Table 18. Sinopharm Nivolumab Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Allergan Basic Information, Manufacturing Base and Competitors
Table 20. Allergan Nivolumab Injection Major Business
Table 21. Allergan Nivolumab Injection Total Revenue (USD Million) (2018-2019)
Table 22. Allergan SWOT Analysis
Table 23. Allergan Nivolumab Injection Product and Services
Table 24. Allergan Nivolumab Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Ono Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 26. Ono Pharmaceutical Nivolumab Injection Major Business
Table 27. Ono Pharmaceutical Nivolumab Injection Total Revenue (USD Million) (2018-2019)
Table 28. Ono Pharmaceutical SWOT Analysis
Table 29. Ono Pharmaceutical Nivolumab Injection Product and Services
Table 30. Ono Pharmaceutical Nivolumab Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 32. Bristol-Myers Squibb Nivolumab Injection Major Business
Table 33. Bristol-Myers Squibb Nivolumab Injection Total Revenue (USD Million) (2018-2019)
Table 34. Bristol-Myers Squibb SWOT Analysis
Table 35. Bristol-Myers Squibb Nivolumab Injection Product and Services
Table 36. Bristol-Myers Squibb Nivolumab Injection Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Global Nivolumab Injection Sales by Manufacturer (2018-2019) (K Units)
Table 38. Global Nivolumab Injection Revenue by Manufacturer (2018-2019) (USD Million)
Table 39. Global Nivolumab Injection Sales by Regions (2015-2020) (K Units)
Table 40. Global Nivolumab Injection Sales Market Share by Regions (2015-2020)
Table 41. Global Nivolumab Injection Revenue by Regions (2015-2020) (USD Million)
Table 42. North America Nivolumab Injection Sales by Countries (2015-2020) (K Units)
Table 43. North America Nivolumab Injection Sales Market Share by Countries (2015-2020)
Table 44. North America Nivolumab Injection Revenue by Countries (2015-2020) (USD Million)
Table 45. North America Nivolumab Injection Revenue Market Share by Countries (2015-2020)
Table 46. Europe Nivolumab Injection Sales by Countries (2015-2020) (K Units)
Table 47. Europe Nivolumab Injection Sales Market Share by Countries (2015-2020)
Table 48. Europe Nivolumab Injection Revenue by Countries (2015-2020) (USD Million)
Table 49. Asia-Pacific Nivolumab Injection Sales by Regions (2015-2020) (K Units)
Table 50. Asia-Pacific Nivolumab Injection Sales Market Share by Regions (2015-2020)
Table 51. Asia-Pacific Nivolumab Injection Revenue by Regions (2015-2020) (USD Million)
Table 52. South America Nivolumab Injection Sales by Countries (2015-2020) (K Units)
Table 53. South America Nivolumab Injection Sales Market Share by Countries (2015-2020)
Table 54. South America Nivolumab Injection Revenue by Countries (2015-2020) (USD Million)
Table 55. South America Nivolumab Injection Revenue Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Nivolumab Injection Sales by Countries (2015-2020) (K Units)
Table 57. Middle East & Africa Nivolumab Injection Sales Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Nivolumab Injection Revenue by Countries (2015-2020) (USD Million)
Table 59. Middle East & Africa Nivolumab Injection Revenue Market Share by Countries (2015-2020)
Table 60. Global Nivolumab Injection Sales by Type (2015-2020) (K Units)
Table 61. Global Nivolumab Injection Sales Share by Type (2015-2020)
Table 62. Global Nivolumab Injection Revenue by Type (2015-2020) (USD Million)
Table 63. Global Nivolumab Injection Revenue Share by Type (2015-2020)
Table 64. Global Nivolumab Injection Sales by Application (2015-2020) (K Units)
Table 65. Global Nivolumab Injection Sales Share by Application (2015-2020)
Table 66. Global Nivolumab Injection Sales Forecast by Regions (2021-2025) (K Units)
Table 67. Global Nivolumab Injection Market Share Forecast by Regions (2021-2025)
Table 68. Global Nivolumab Injection Sales Forecast by Type (2021-2025) (K Units)
Table 69. Global Nivolumab Injection Market Share Forecast by Type (2021-2025)
Table 70. Global Nivolumab Injection Sales Forecast by Application (2021-2025)
Table 71. Global Nivolumab Injection Market Share Forecast by Application (2021-2025)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Nivolumab Injection Picture
Figure 2. Global Sales Market Share of Nivolumab Injection by Type in 2019
Figure 3. 100IU Picture
Figure 4. 50IU Picture
Figure 5. Other Picture
Figure 6. Nivolumab Injection Sales Market Share by Application in 2018
Figure 7. Unresectable Melanoma Picture
Figure 8. Metastatic Melanoma Picture
Figure 9. Metastatic Squamous NSCLC Picture
Figure 10. Classical Hodgkin Lymphoma Picture
Figure 11. Renal Cell Carcinoma Picture
Figure 12. Other Picture
Figure 13. Global Nivolumab Injection Market Status and Outlook (2015-2025) (USD Million)
Figure 14. United States Nivolumab Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Canada Nivolumab Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Mexico Nivolumab Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Germany Nivolumab Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 18. France Nivolumab Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 19. UK Nivolumab Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Russia Nivolumab Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Italy Nivolumab Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 22. China Nivolumab Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Japan Nivolumab Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Korea Nivolumab Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 25. India Nivolumab Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Southeast Asia Nivolumab Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Australia Nivolumab Injection Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 28. Brazil Nivolumab Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Egypt Nivolumab Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Saudi Arabia Nivolumab Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 31. South Africa Nivolumab Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Turkey Nivolumab Injection Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Global Nivolumab Injection Sales Market Share by Manufacturer in 2019
Figure 34. Global Nivolumab Injection Revenue Market Share by Manufacturer in 2019
Figure 35. Top 3 Nivolumab Injection Manufacturer (Revenue) Market Share in 2019
Figure 36. Top 6 Nivolumab Injection Manufacturer (Revenue) Market Share in 2019
Figure 37. Key Manufacturer Market Share Trend
Figure 38. Global Nivolumab Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 39. Global Nivolumab Injection Revenue and Growth Rate (2015-2020) (USD Million)
Figure 40. Global Nivolumab Injection Revenue Market Share by Regions (2015-2020)
Figure 41. Global Nivolumab Injection Revenue Market Share by Regions in 2018
Figure 42. North America Nivolumab Injection Sales and Growth Rate (2015-2020)
Figure 43. Europe Nivolumab Injection Sales and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Nivolumab Injection Sales and Growth Rate (2015-2020)
Figure 45. South America Nivolumab Injection Sales and Growth Rate (2015-2020)
Figure 46. Middle East & Africa Nivolumab Injection Sales and Growth Rate (2015-2020)
Figure 47. North America Nivolumab Injection Revenue and Growth Rate (2015-2020) (USD Million)
Figure 48. North America Nivolumab Injection Sales Market Share by Countries (2015-2020)
Figure 49. North America Nivolumab Injection Sales Market Share by Countries in 2018
Figure 50. North America Nivolumab Injection Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 51. North America Nivolumab Injection Revenue Market Share by Countries in 2018
Figure 52. United States Nivolumab Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Canada Nivolumab Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Mexico Nivolumab Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 55. Europe Nivolumab Injection Revenue and Growth Rate (2015-2020) (USD Million)
Figure 56. Europe Nivolumab Injection Revenue Market Share by Countries (2015-2020)
Figure 57. Europe Nivolumab Injection Revenue Market Share by Countries in 2019
Figure 58. Germany Nivolumab Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 59. UK Nivolumab Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 60. France Nivolumab Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Russia Nivolumab Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Italy Nivolumab Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Asia-Pacific Nivolumab Injection Revenue and Growth Rate (2015-2020) (USD Million)
Figure 64. Asia-Pacific Nivolumab Injection Sales Market Share by Regions 2019
Figure 65. Asia-Pacific Nivolumab Injection Revenue Market Share by Regions 2019
Figure 66. China Nivolumab Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Japan Nivolumab Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Korea Nivolumab Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 69. India Nivolumab Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Southeast Asia Nivolumab Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 71. South America Nivolumab Injection Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. South America Nivolumab Injection Sales Market Share by Countries in 2019
Figure 73. South America Nivolumab Injection Revenue Market Share by Countries in 2019
Figure 74. Brazil Nivolumab Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Argentina Nivolumab Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Middle East and Africa Nivolumab Injection Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. Middle East and Africa Nivolumab Injection Sales Market Share by Countries in 2019
Figure 78. Middle East and Africa Nivolumab Injection Revenue Market Share by Countries (2015-2020)
Figure 79. Middle East and Africa Nivolumab Injection Revenue Market Share by Countries in 2019
Figure 80. Saudi Arabia Nivolumab Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Egypt Nivolumab Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Turkey Nivolumab Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 83. South Africa Nivolumab Injection Sales and Growth Rate (2015-2020) (K Units)
Figure 84. Global Nivolumab Injection Sales and Growth Rate (2021-2025) (K Units)
Figure 85. Global Nivolumab Injection Revenue and Growth Rate (2021-2025) (USD Million)
Figure 86. North America Sales Nivolumab Injection Market Forecast (2021-2025) (K Units)
Figure 87. Europe Sales Nivolumab Injection Market Forecast (2021-2025) (K Units)
Figure 88. Asia-Pacific Sales Nivolumab Injection Market Forecast (2021-2025) (K Units)
Figure 89. South America Sales Nivolumab Injection Market Forecast (2021-2025) (K Units)
Figure 90. Middle East & Africa Sales Nivolumab Injection Market Forecast (2021-2025) (K Units)
Figure 91. Sales Channel: Direct Channel vs Indirect Channel
ベンダムスチン注射の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Bendamustine Injection market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Bendamustine Injection…- 黒色腫検出の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Melanoma Detection market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Melanoma Detection market …
- 転移性大腸がん治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Metastatic Colorectal Cancer Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Metast…
- 転移性乳がん治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Metastatic Breast Cancer Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Metastatic…
- 注射用ミカファンギンナトリウムの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Micafungin Sodium for Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…